Ziva DRA supports pharmaceutical investors, manufacturers, project developers and international companies across new manufacturing projects, facility expansion, GMP planning, regulatory strategy, business compliance, market intelligence and Bangladesh investment support.
A pharmaceutical manufacturing project requires more than construction. Product strategy, facility design, GMP expectations, utilities, quality systems, licensing, business structure and market opportunity should align before major capital is committed.
A pharmaceutical facility should be planned around what it will manufacture, how materials and personnel will move, which quality systems will govern operations and which regulatory requirements the facility must ultimately satisfy.
Ziva DRA helps clients integrate regulatory and GMP considerations into the wider business and investment architecture before those requirements become expensive retrofit problems.
The engagement can begin at feasibility stage or support an existing facility expansion, manufacturing-line addition, technology transfer or compliance-upgrade program.
The exact project scope depends on product portfolio, facility status, investment model and regulatory objectives.
Evaluate product categories, market demand, competition and the strategic case for manufacturing.
Align production activities, material flow, personnel flow and functional areas with the intended operation.
Consider manufacturing equipment, utilities, support systems and infrastructure requirements.
Build quality and manufacturing-compliance principles into the project from the design stage.
Map relevant regulatory, licensing and operational approvals around the facility program.
Connect the industrial project with company, investment, trade, tax and operational structures.
Projects can range from greenfield manufacturing plants to targeted expansion of an existing facility.
New pharmaceutical manufacturing projects developed from the ground up.
Capacity expansion, additional manufacturing areas and supporting infrastructure.
Introduction of new dosage forms, equipment lines or manufacturing capability.
Facility and quality improvements supporting stronger GMP readiness.
A stage-based project architecture helps strategic, technical and regulatory decisions stay aligned.
The project can combine GMP, regulatory, market, investment and business-compliance workstreams as required.
Manufacturing, quality and compliance support for pharmaceutical facility development.
Explore GMP ConsultingConnect product and facility development with regulatory market-access strategy.
Explore Regulatory AffairsEvaluate demand, target products, market structure and manufacturing opportunity.
Explore Market ResearchCombine market, regulatory and investment intelligence into a decision-oriented project report.
Explore Market Entry ReportsSupport establishment of an appropriate Bangladesh business entity where required.
Explore Company FormationSupport foreign-investment and related business-establishment workstreams.
Explore Investment SupportSupport import-related business requirements for equipment, materials and operations.
Explore Import RegistrationConnect the project with relevant tax and VAT compliance workstreams.
Explore Tax & VAT ServicesUnderstand pharmaceutical raw-material, supplier and sourcing considerations.
Explore API & ChemicalsThe earlier regulatory and operational constraints are identified, the easier they are to incorporate into project design.
Build the facility around the future regulated operation.
Confirm whether the facility concept is commercially sustainable.
Good pharmaceutical project planning transforms regulatory requirements from late-stage obstacles into early-stage design inputs.
Identify regulatory, quality and project constraints sooner.
Connect facility decisions with manufacturing requirements.
Align investment, GMP, business and regulatory workstreams.
Create a stronger foundation for portfolio and facility growth.
Yes. Support can include feasibility, market intelligence, GMP consulting, regulatory strategy and connected business-compliance workstreams depending on project scope.
Yes. Expansion projects can be structured around new capacity, production lines, product categories or compliance improvements.
Yes. Incorporating GMP and manufacturing requirements early can help reduce expensive design revisions later in the project.
Yes. Market Research, Competitor Analysis and Market Entry Reports can help evaluate product demand and commercial conditions before larger capital commitments.
Relevant company-establishment, investment and business-compliance workstreams can be connected with the wider pharma project.
Yes. API, excipient and chemical supplier intelligence can form part of the manufacturing and supply-chain strategy.
Share your proposed product portfolio, manufacturing capacity, facility status, investment model, target market and current project stage with Ziva DRA. We can help structure the market, GMP, regulatory, investment and business-compliance workstreams around your pharma project.